Presynaptic Ca2+ requirements and developmental regulation of posttetanic potentiation at the calyx of Held.
Large excitatory synapses in the auditory system, such as the calyx of Held, faithfully transmit trains of action potentials up to a frequency of a few hundred hertz, and these synapses are thought to display a limited repertoire of synaptic plasticity. Here, we show that brief trains of 100 Hz stimulation induce posttetanic potentiation (PTP) of transmitter release at the calyx of Held. In young rats [postnatal day 4 (P4) to P6], PTP could be induced with shorter 100 Hz trains compared with older age groups (P8-P10 and P12-P14), but the maximal amount of PTP was similar, with 200% of control EPSC amplitude. The size of the readily releasable pool of vesicles was not increased significantly during PTP. Bath application of the membrane-permeable Ca2+ chelator EGTA-AM suppressed PTP, indicating a role for presynaptic Ca2+ in PTP at the calyx of Held. Presynaptic Ca2+ imaging showed that the intracellular Ca2+ concentration, [Ca2+]i, was increased by 40-120 nM at the peak of PTP, and this "residual" [Ca2+]i decayed in parallel with PTP, with time constants in the range of 10-60 s. During whole-cell recording of the presynaptic calyx of Held, PTP was absent, and the decay of residual [Ca2+]i was strongly accelerated. The data show that the calyx of Held expresses a mechanism of transmitter release potentiation in which a small, sustained elevation of basal [Ca2+]i increases the transmitter release probability after trains of high-frequency stimulation.
Korogod
Natalya
N
AG Synaptische Dynamik und Modulation and Abteilung Membranbiophysik, Max-Planck-Institut für Biophysikalische Chemie, D-37077 Göttingen, Germany.
Lou
Xuelin
X
Schneggenburger
Ralf
R
D000367:Age Factors; D000814:Aniline Compounds; D000818:Animals; D000831:Animals, Newborn; D001581:Benzothiadiazines / Q000494:pharmacology; D001933:Brain Stem / Q000166:cytology; D002118:Calcium / Q000378:metabolism*; D003952:Diagnostic Imaging / Q000379:methods; D004307:Dose-Response Relationship, Radiation; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D004558:Electric Stimulation; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D018698:Glutamic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D007736:Kynurenic Acid / Q000494:pharmacology; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects*; D009474:Neurons / Q000166:cytology; D010080:Oxazoles; D018408:Patch-Clamp Techniques / Q000379:methods; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D013569:Synapses / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D013997:Time Factors
D000814:Aniline Compounds; D001581:Benzothiadiazines; D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; C500962:Fura-4F; D010080:Oxazoles; D018698:Glutamic Acid; D004533:Egtazic Acid; C046770:EGTA acetoxymethyl ester; D007736:Kynurenic Acid; C004639:cyclothiazide; D002118:Calcium